Cofoe Medical Technology Co.,Ltd. (SHE:301087)

Cofoe Medical Technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,297	1,279	1,569	1,450	1,989	557.09
Trading Asset Securities	1,239	1,357	851.3	1,243	1,537	-
Cash & Short-Term Investments	2,536	2,636	2,421	2,693	3,527	557.09
Cash Growth	-4.70%	8.90%	-10.12%	-23.63%	533.03%	51.01%
Accounts Receivable	443.83	401.84	486	617.22	362.02	196.65
Other Receivables	59.87	17.55	30.63	46.15	32.42	34.07
Receivables	503.7	419.39	516.63	663.37	394.44	230.72
Inventory	647.99	659.58	634.72	529.36	480.75	402.37
Other Current Assets	205.91	210.42	258.66	314.63	117.11	65.76
Total Current Assets	3,894	3,925	3,831	4,201	4,519	1,256
Property, Plant & Equipment	1,742	1,637	1,696	1,598	879.7	262.36
Long-Term Investments	91.52	61.43	64.93	5.26	5.28	5.58
Goodwill	368.91	364.34	242.41	230.5	48.59	11.6
Other Intangible Assets	278.92	235.93	240.55	248.25	202.27	203.46
Long-Term Deferred Tax Assets	52.57	44.97	34.72	31.42	12.61	10.64
Long-Term Deferred Charges	64.78	52.8	50.92	60.32	47.75	36.78
Other Long-Term Assets	47.55	100.23	84.11	35.95	92.07	8.22
Total Assets	6,540	6,423	6,244	6,411	5,807	1,795
Accounts Payable	515.05	467.65	482.97	634.89	448.1	336
Accrued Expenses	42.72	96.77	92.09	144.45	58.84	39.24
Short-Term Debt	743.97	548.61	402.43	282.74	83.07	280
Current Portion of Long-Term Debt	-	114.01	12	13.81	10	-
Current Portion of Leases	-	54.12	55.01	51.69	41.89	-
Current Income Taxes Payable	34.52	17.8	3.76	28.47	23.31	20.36
Current Unearned Revenue	31.57	33.18	16.84	8.98	10	3.08
Other Current Liabilities	270.17	29.57	21.31	22.56	7.38	54.95
Total Current Liabilities	1,638	1,362	1,086	1,188	682.58	733.64
Long-Term Debt	-	125.17	94.1	30.03	5	10
Long-Term Leases	69.34	61.48	77.24	84.55	93.19	-
Long-Term Unearned Revenue	59.87	55.7	55.62	51.7	56.84	47.17
Long-Term Deferred Tax Liabilities	22.6	15.03	15.7	16.68	4.36	3.8
Other Long-Term Liabilities	-	1.21	6.94	7.41	-	-
Total Liabilities	1,790	1,620	1,336	1,378	841.97	794.61
Common Stock	208.9	209.09	209.24	208.49	160	120
Additional Paid-In Capital	3,948	3,931	3,933	3,913	3,917	430.69
Retained Earnings	762.9	868.67	923.4	914.88	869.8	445.72
Treasury Stock	-206.42	-212.12	-166.93	-15.74	-	-
Total Common Equity	4,714	4,797	4,899	5,020	4,947	996.42
Minority Interest	36.84	5.75	9	12.57	17.94	3.54
Shareholders' Equity	4,750	4,802	4,908	5,033	4,965	999.95
Total Liabilities & Equity	6,540	6,423	6,244	6,411	5,807	1,795
Total Debt	813.3	903.4	640.77	462.82	233.15	290
Net Cash (Debt)	1,723	1,733	1,780	2,231	3,293	267.09
Net Cash Growth	-0.81%	-2.65%	-20.20%	-32.27%	1133.06%	-13.62%
Net Cash Per Share	8.48	8.42	8.69	10.70	20.00	1.71
Filing Date Shares Outstanding	203.2	203.39	203.7	203.94	208	156
Total Common Shares Outstanding	203.2	203.39	205.04	203.94	208	156
Working Capital	2,256	2,564	2,744	3,013	3,836	522.29
Book Value Per Share	23.20	23.58	23.89	24.62	23.78	6.39
Tangible Book Value	4,066	4,196	4,416	4,542	4,696	781.36
Tangible Book Value Per Share	20.01	20.63	21.54	22.27	22.58	5.01
Buildings	-	1,232	1,248	1,107	71.62	70.9
Machinery	-	479.08	407.64	259.17	193.3	133.26
Construction In Progress	-	50.13	49.33	171.39	508.49	83.44

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.